1.
Köşeci T, Olgun P, Ata S, Bayram E, Sungur MA, Eser K, Duman BB, Çil T. Prognostic importance of peripheral blood parameters in HER-2 positive metastatic breast cancer treated by pertuzumab, trastuzumab and docetaxel. Med Sci Discov [Internet]. 2021 Dec. 27 [cited 2024 Apr. 19];8(12):730-4. Available from: https://medscidiscovery.com/index.php/msd/article/view/646